Relay Therapeutics (RLAY) Interest Coverage Ratio (2019 - 2023)
Relay Therapeutics (RLAY) reported Interest Coverage Ratio of 33725.67 for Q1 2023, down 1029.19% year-over-year from 3629.58 in Q1 2022, and down 1029.19% quarter-over-quarter from 2986.71 in Q1 2022.
Relay Therapeutics (RLAY) Interest Coverage Ratio (2019 - 2023) Analysis & Trends
Relay Therapeutics (RLAY) has 5 years of Interest Coverage Ratio data on file, last reported at 33725.67 in Q1 2023.
- Interest Coverage Ratio for Q1 2023 came in at 33725.67, down 1029.19% year-over-year; the trailing twelve-month figure through Dec 2023 was 124333.33 (down 772.44% YoY), and the FY2021 annual result was 91174.5, down 2514.51% from the prior year.
- Interest Coverage Ratio fell to 33725.67 in Q1 2023 per RLAY's latest filing, from 2986.71 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 4373.5 in Q4 2020 and troughed at 33725.67 in Q1 2023.
- A 5-year average of 11326.99 and a median of 8481.0 in 2021 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2020 and 2023: Interest Coverage Ratio surged 66.58% in 2020, then tumbled 1029.19% in 2023.
- A 5-year view of Interest Coverage Ratio shows it stood at 21908.0 in 2019, then soared by 119.96% to 4373.5 in 2020, then plunged by 293.92% to 8481.0 in 2021, then soared by 64.78% to 2986.71 in 2022, then plunged by 1029.19% to 33725.67 in 2023.
- Business Quant data shows RLAY's Interest Coverage Ratio at 33725.67 in Q1 2023, 2986.71 in Q1 2022, and 8481.0 in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Relay Therapeutics | 2.86 Bn | 2.86 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | -33,725.67 |
| Mar 31, 2022 | -2,986.71 |
| Mar 31, 2021 | -8,481.00 |
| Dec 31, 2020 | 4,373.50 |
| Sep 30, 2020 | -7,321.40 |
| Jun 30, 2020 | -9,239.67 |
| Sep 30, 2019 | -21,908.00 |